Terms: = Ovarian cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
20 results:
1. Clinical characteristic and prognostic factors in high-grade endometrial neuroendocrine carcinoma.
Zhang Z; Wang J; Wu X; Liu Y; Xi X
J Obstet Gynaecol Res; 2022 Aug; 48(8):2180-2188. PubMed ID: 35778826
[TBL] [Abstract] [Full Text] [Related]
2. Outcomes of the conservative management of the patients with endometrial intraepithelial neoplasia/endometrial cancer: Wait or treat!
İşçi Bostancı E; Durmuş Y; Duru Çöteli AS; Kayıkçıoğlu F; Boran N
Turk J Med Sci; 2021 Aug; 51(4):2066-2072. PubMed ID: 34013707
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathologic characteristics and prognosis comparison of the uterine high grade endometrial carcinomas.
Sucu M; Kucukgoz Gulec U; Paydas S; Guzel AB; Kilic Bagir E; Vardar MA
Ginekol Pol; 2021; 92(4):278-283. PubMed ID: 33751504
[TBL] [Abstract] [Full Text] [Related]
4. THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Camastra S; Mazzi V; Miccoli M; Benvenga S; Antonelli A
Eur J Endocrinol; 2021 Jan; 184(1):R29-R40. PubMed ID: 33112294
[TBL] [Abstract] [Full Text] [Related]
5. Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.
Liu HJ; Qin Y; Zhao ZH; Zhang Y; Yang JH; Zhai DH; Cui F; Luo C; Lu MX; Liu PP; Xu HW; Li K; Sun B; Chen S; Zhou HG; Yang C; Sun T
Theranostics; 2020; 10(20):9083-9099. PubMed ID: 32802180
[No Abstract] [Full Text] [Related]
6. Utilization and treatment Patterns of Cytoreduction Surgery and Intraperitoneal Chemotherapy in the United States.
Ellis RJ; Schlick CJR; Yang AD; Barber EL; Bilimoria KY; Merkow RP
Ann Surg Oncol; 2020 Jan; 27(1):214-221. PubMed ID: 31187369
[TBL] [Abstract] [Full Text] [Related]
7. Challenges and controversies in the conservative management of uterine and ovarian cancer.
Janda M; McGrath S; Obermair A
Best Pract Res Clin Obstet Gynaecol; 2019 Feb; 55():93-108. PubMed ID: 30243603
[TBL] [Abstract] [Full Text] [Related]
8. Value of combined adjuvant chemotherapy and radiation on survival for stage III uterine cancer: is less radiation equal to more?
Wang CJ; Christie A; Folkert MR; Xie XJ; Albuquerque K
J Gynecol Oncol; 2018 Jul; 29(4):e49. PubMed ID: 29770620
[TBL] [Abstract] [Full Text] [Related]
9. Folate Receptor Alpha Expression in Platinum Resistant/Refractory ovarian Carcinomas and Primary Endocervical Adenocarcinomas.
Rubinsak LA; Cohen C; Khanna N; Horowitz IR; Hanley KZ
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):567-572. PubMed ID: 27941566
[TBL] [Abstract] [Full Text] [Related]
10. Survival Differences Among Uterine Papillary Serous, Clear Cell and Grade 3 Endometrioid Adenocarcinoma Endometrial cancers: A National cancer Database Analysis.
McGunigal M; Liu J; Kalir T; Chadha M; Gupta V
Int J Gynecol Cancer; 2017 Jan; 27(1):85-92. PubMed ID: 27759595
[TBL] [Abstract] [Full Text] [Related]
11. Association of the immunohistochemical detection of gamma-glutamyl transferase expression with clinicopathological findings in postmenopausal women with endometrioid adenocarcinoma of the uterus.
Pitynski K; Ozimek T; Galuszka N; Banas T; Milian-Ciesielska K; Pietrus M; Okon K; Mikos M; Juszczyk G; Sinczak-Kuta A; Stoj A
J Physiol Pharmacol; 2016 Jun; 67(3):395-402. PubMed ID: 27512000
[TBL] [Abstract] [Full Text] [Related]
12. A survey on fertility management in young women of reproductive age treated with chemotherapy.
Abe A; Kuwahara A; Iwasa T; Nishimura M; Irahara M
Int J Clin Oncol; 2016 Dec; 21(6):1183-1190. PubMed ID: 27402102
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium.
Lawrenson K; Pakzamir E; Liu B; Lee JM; Delgado MK; Duncan K; Gayther SA; Liu S; Roman L; Mhawech-Fauceglia P
PLoS One; 2015; 10(7):e0130909. PubMed ID: 26132201
[TBL] [Abstract] [Full Text] [Related]
14. A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study.
Gu R; Jia W; Zeng Y; Rao N; Hu Y; Li S; Wu J; Jin L; Chen L; Long M; Chen K; Chen L; Xiao Q; Wu M; Song E; Su F
BMC Cancer; 2012 May; 12():161. PubMed ID: 22548922
[TBL] [Abstract] [Full Text] [Related]
15. Postoperative chylous ascites in patients with gynecologic malignancies.
Han D; Wu X; Li J; Ke G
Int J Gynecol Cancer; 2012 Feb; 22(2):186-90. PubMed ID: 22146765
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathological characteristics of ovarian carcinomas associated with endometriosis.
Kondi-Pafiti A; Papakonstantinou E; Iavazzo C; Grigoriadis C; Salakos N; Gregoriou O
Arch Gynecol Obstet; 2012 Feb; 285(2):479-83. PubMed ID: 21717140
[TBL] [Abstract] [Full Text] [Related]
17. Galectin-3 expression in uterine endometrioid adenocarcinoma: comparison of staining in conventional tumor glands and in areas of MELF pattern myometrial invasion.
Stewart CJ; Crook ML
Int J Gynecol Pathol; 2010 Nov; 29(6):555-61. PubMed ID: 20881856
[TBL] [Abstract] [Full Text] [Related]
18. Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.
Cooper WN; Dickinson RE; Dallol A; Grigorieva EV; Pavlova TV; Hesson LB; Bieche I; Broggini M; Maher ER; Zabarovsky ER; Clark GJ; Latif F
Oncogene; 2008 Mar; 27(12):1805-11. PubMed ID: 17891178
[TBL] [Abstract] [Full Text] [Related]
19. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
Blumenfeld Z
Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
[TBL] [Abstract] [Full Text] [Related]
20. FTIR and Raman microspectroscopy of normal, benign, and malignant formalin-fixed ovarian tissues.
Krishna CM; Sockalingum GD; Bhat RA; Venteo L; Kushtagi P; Pluot M; Manfait M
Anal Bioanal Chem; 2007 Mar; 387(5):1649-56. PubMed ID: 17043798
[TBL] [Abstract] [Full Text] [Related]
